Mr. Chirfi Guindo - 03 Aug 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: Chief Marketing Officer
Signature: /s/ Jon Filderman, as attorney-in-fact for Chirfi Guindo
Issuer symbol: MRK
Transactions as of: 03 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Aug 2022, 16:04:11 UTC
Previous filing: 28 Apr 2023
Next filing: 04 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRK	Common Stock						3	03 Aug 2022	Direct
holding	MRK	Common Stock-401(k) Plan						51	03 Aug 2022	By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Restricted Stock Unit	Award	$0	+110,705		$0.000000	110,705	03 Aug 2022	Common Stock	110,705		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025.